Schedule 13G ownership disclosure

GALMED PHARMACEUTICALS LTD

Security class unavailable · CUSIP: M47238106

Event date: 2020-07-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.0100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001079973-20-000628
Form type
SC 13G
Filer
Galmed Pharmaceuticals Ltd.
CIK
CIK 1595353
Filed
Jul 28, 2020
Reporting period
Jul 27, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub